Loading clinical trials...
Loading clinical trials...
A Phase 1 Prospective Study of the Miromatrix External Liver Assist Product (miroliverELAP®) for Liver Support in Adults With Acute Liver Failure.
Conditions
Interventions
miroliverELAP treatment
Locations
8
United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
University of Michigan Medical School
Ann Arbor, Michigan, United States
University of Minnesota Medical School
Minneapolis, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
Mount Sinai Recanati/Miller Transplantation Institute
New York, New York, United States
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Start Date
October 5, 2024
Primary Completion Date
January 22, 2026
Completion Date
January 22, 2026
Last Updated
March 6, 2026
NCT07329036
NCT06831643
NCT06837766
NCT06872372
NCT06987968
NCT07276568
Lead Sponsor
Miromatrix Medical Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions